| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/19/2001 | CN1327389A Coupling factor 6 inhibitor and potentiator and use thereof |
| 12/19/2001 | CN1327382A Improved formulation for topical non-invasive application in vivo |
| 12/19/2001 | CN1326928A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof |
| 12/19/2001 | CN1326777A Medicinal bag for preventing cold |
| 12/19/2001 | CN1326770A Plant health drink for relieving cough and diminishing inflammation |
| 12/19/2001 | CN1076352C 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agaonists |
| 12/19/2001 | CN1076348C 3-bustituted oxindole derivatives as patassium path regulating agent |
| 12/19/2001 | CN1076200C Medicine for curing cardiovascular diseases |
| 12/18/2001 | US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
| 12/18/2001 | US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors |
| 12/18/2001 | US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders |
| 12/18/2001 | US6331527 Promoter smooth muscle cell expression |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331303 LKTA deletion mutant of P. haemolytica |
| 12/18/2001 | US6331298 Wound healing and treatment of fibrotic disorders |
| 12/18/2001 | CA2202484C Use of indole derivatives for the treatment of various diseases |
| 12/18/2001 | CA2178161C Indole derivatives |
| 12/18/2001 | CA2082923C Sulfonyl compounds |
| 12/18/2001 | CA2057917C New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094368A1 2-aminocarbonyl-9h-purine derivatives |
| 12/13/2001 | WO2001094351A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | WO2001094346A1 1,3,8-TRIAZA-SPIRO'4,5!DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS |
| 12/13/2001 | WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 12/13/2001 | WO2001094338A1 Admantane derivatives |
| 12/13/2001 | WO2001094325A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | WO2001093885A1 Therapeutic agents - ii |
| 12/13/2001 | WO2001093884A1 Therapeutic agents - i |
| 12/13/2001 | WO2001093883A1 Therapeutic agents - iii |
| 12/13/2001 | WO2001093878A2 Bismuth compounds for the treatment and prevention of mucositis |
| 12/13/2001 | WO2001093867A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001093853A1 Management of snoring by oral administration of dimethyl sulfone |
| 12/13/2001 | WO2001093846A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
| 12/13/2001 | WO2001093845A2 Carboxyalkylether-acat inhibitor combinations |
| 12/13/2001 | WO2001093824A1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals |
| 12/13/2001 | WO2001063368A3 Compliance tracking method |
| 12/13/2001 | WO2001045668A3 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 12/13/2001 | WO2001044445A3 Human lyases and associated proteins |
| 12/13/2001 | WO2001044228A3 Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses |
| 12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
| 12/13/2001 | WO2001025219A3 Piperazine compounds |
| 12/13/2001 | US20010051613 Water solubility |
| 12/13/2001 | US20010050242 Weight-specific elixir dosage calculator |
| 12/13/2001 | CA2413906A1 Carboxyalkylether-acat inhibitor combinations |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411596A1 Therapeutic agents - ii |
| 12/13/2001 | CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | CA2410577A1 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409015A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/12/2001 | EP1161950A1 Use of diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| 12/12/2001 | EP1161949A1 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161422A1 Amine derivatives as protease inhibitors |
| 12/12/2001 | EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161410A1 Retinoid antagonists and use thereof |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161259A1 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 12/12/2001 | EP1161247A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP1161234A2 Method for delivering benzidine prostaglandins by inhalation |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP1161225A1 Metered dose inhalers with isobutane as propellant |
| 12/12/2001 | EP0766570B1 Methods for treating respiratory disease |
| 12/12/2001 | EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326462A Betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 12/12/2001 | CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III |
| 12/12/2001 | CN1326440A Piperdine CCR-3 receptor antagonists |
| 12/12/2001 | CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 12/12/2001 | CN1325715A Medicine for treating chronic trachitis |
| 12/12/2001 | CN1325712A Powdered inhalation 'Biqingpen' and its preparing process |
| 12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 12/11/2001 | US6329397 Hydroxy pipecolate hydroxamic acid derivatives |
| 12/11/2001 | US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders |
| 12/11/2001 | US6329382 Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine remedies/preventives for respiratory diseases |
| 12/11/2001 | US6329370 Cardiovascular disorders and tumor necrosis factor (hereinafter tnf.sub..alpha.), a cytokine with pro-inflammatory activity |
| 12/11/2001 | US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders. |
| 12/11/2001 | US6329344 Urea derivative of alkylene dioxyfuran ethers |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/09/2001 | CA2347337A1 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| 12/08/2001 | CA2349776A1 Novel crystalline forms of (3s-trans)-2-¬3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2h-1-benzopyran-7-yl|-4-(trifluoromethyl)-benzoic acid |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |